Alexander Fine

242 posts

Alexander Fine banner
Alexander Fine

Alexander Fine

@Alexander_Fine

Scientist in cancer genomics and computational discovery at @FoundationATCG. All opinions are my own. 🏳️‍🌈 he/him.

Cambridge, MA Katılım Eylül 2015
190 Takip Edilen217 Takipçiler
Alexander Fine retweetledi
Foundation Medicine
Foundation Medicine@FoundationATCG·
#Research in @TheLancet showcased positive results of CUPISCO, a randomized, precision oncology study designed to prospectively assess the efficacy of molecularly guided therapy in patients w/ unfavorable subsets of cancer-of-unknown-primary. Learn more: bit.ly/3yoGFml
Foundation Medicine tweet media
English
0
1
2
334
Alexander Fine retweetledi
Jay Bradner, M.D.
Jay Bradner, M.D.@jaybradner·
Today in @ScienceMagazine, together with my former colleagues at NIBR, we report the discovery and characterization of first molecular glue degraders of the WIZ transcription factor (TF) for fetal hemoglobin derepression and therapeutic consideration in Sickle Cell Disease. 1/10 science.org/doi/10.1126/sc…
English
17
133
697
288.4K
Alexander Fine retweetledi
Garrett Frampton
Garrett Frampton@BostonGenomics·
Hot science! Look at the separation of those curves! Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic Cancer academic.oup.com/oncolo/article…
English
0
8
9
2.1K
Alexander Fine retweetledi
Foundation Medicine
Foundation Medicine@FoundationATCG·
#Announcing the launch of FoundationOne®Monitor* for research use in retrospective studies - available for biopharma customers, test provides unique access to our ctDNA tumor fraction biomarker: bit.ly/3MPXSsb *Research Use Only. Not for use in diagnostic procedures
English
0
4
7
1.9K
Alexander Fine retweetledi
Aadel Chaudhuri, MD PhD
Aadel Chaudhuri, MD PhD@aadel_chaudhuri·
Thank you for involving me in this effort! #ctDNA pre->on-tx change across multiple platforms & NSCLC #Immunotherapy studies correlate significantly with PFS, OS, tumor response. @CancerResrch multi-institutional harmonization collab between #academia, #pharma, @FDAOncology
Aadel Chaudhuri, MD PhD tweet media
Elsa Anagnostou@ValsamoA

Critical @CancerResrch collaborative effort across #Academia #pharma and @FDAOncology on #ctDNA dynamics for response monitoring during #immunotherapy just published in @JCOPO_ASCO. Read here: trib.al/e6Fk2Na #CTMoniTR #WhatFriendsDoes #ctDNAFriends #LCSM @hopkinskimmel

English
0
5
17
0
Alexander Fine retweetledi
Friends of Cancer Research
Friends of Cancer Research@CancerResrch·
IT’S HERE! Our #ctMoniTR Step 1 Manuscript was just published in @JCOPO_ASCO . Key takeaway: Our unique consortium demonstrated reductions in ctDNA are strongly associated with better clinical outcomes. What about the details? A🧵 trib.al/e6Fk2Na
Friends of Cancer Research tweet media
English
1
5
19
0
Alexander Fine retweetledi
Foundation Medicine
Foundation Medicine@FoundationATCG·
In partnership with @flatironhealth, @genentech and a network of community oncology practices, we are excited to release new research on tumor profiling results from the ongoing Prospective Clinicogenomic (PCG) Study. More on this new data and the study: bit.ly/3d8pWsx
English
0
7
14
0
Alexander Fine retweetledi
Foundation Medicine
Foundation Medicine@FoundationATCG·
Proud to share that we have now delivered 1 million reports, generated from our portfolio of CGP tests. Learn more about what this means for patients and the partners we serve in a blog from our CEO, Dr. Brian Alexander (@xelamb): bit.ly/3afPjru
English
0
5
11
0
Alexander Fine retweetledi
Ethan Sokol
Ethan Sokol@EthanSokol·
It’s out! We identify mutual exclusivity between microsatellite instability and HRD. BRCA1/2 mutations in MSI-H tumors are predominantly monoallelic passenger alterations which may not predict PARPi sensitivity. Rather patients may benefit from ICI. ascopubs.org/doi/abs/10.120…
Ethan Sokol tweet media
English
8
71
182
0
Alexander Fine retweetledi
Garrett Frampton
Garrett Frampton@BostonGenomics·
Foundation Medicine and Collaborators to Share Scientific Advances at AACR22 Reinforcing the Power of Genomic Testing in Precision Cancer Care | Foundation Medicine foundationmedicine.com/press-releases…
English
0
2
5
0